Literature DB >> 7536914

Perinatal and neonatal issues of substance abuse.

G L Bell1, K Lau.   

Abstract

Substance abuse during pregnancy can be teratogenic for the fetus and can cause decreased growth parameters in the newborn infant. Short-term and long-term neurobehavioral problems have been documented also in babies born to substance-abusing mothers. The problem of substance abuse during pregnancy and its effects on the fetus is unique in medicine in that it is 100% preventable. Physicians will need to take an active role in leading society to take action in preventing substance abuse during pregnancy, and emphasis on this action should occur long before the woman becomes pregnant. Until medical schools and residency programs take responsibility for teaching the importance of preventing substance abuse and of identifying the substance-abuser, drug and alcohol use will continue to exact its tragic toll on future generations.

Entities:  

Mesh:

Year:  1995        PMID: 7536914     DOI: 10.1016/s0031-3955(16)38946-5

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  9 in total

Review 1.  Maternal substance abuse.

Authors:  L Jain
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

2.  Optical coherence tomography angiography to evaluate murine fetal brain vasculature changes caused by prenatal exposure to nicotine.

Authors:  Raksha Raghunathan; Chih-Hao Liu; Yogeshwari S Ambekar; Manmohan Singh; Rajesh C Miranda; Kirill V Larin
Journal:  Biomed Opt Express       Date:  2020-06-08       Impact factor: 3.732

3.  Neonatal abstinence syndrome.

Authors:  V Tiroumourougane Serane; Ommen Kurian
Journal:  Indian J Pediatr       Date:  2008-06-25       Impact factor: 1.967

4.  Sedatives for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-05-18

Review 5.  Developmental cholinotoxicants: nicotine and chlorpyrifos.

Authors:  T A Slotkin
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

6.  Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States.

Authors:  Valerie E Whiteman; Jason L Salemi; Mulubrhan F Mogos; Mary Ashley Cain; Muktar H Aliyu; Hamisu M Salihu
Journal:  J Pregnancy       Date:  2014-08-28

Review 7.  An overview of available drugs for management of opioid abuse during pregnancy.

Authors:  Jillian Laslo; Jon-Michael Brunner; Daniel Burns; Emily Butler; Autumn Cunningham; Ryan Killpack; Courtney Pyeritz; Kimberly Rinard; Jennifer Childers; Joseph Horzempa
Journal:  Matern Health Neonatol Perinatol       Date:  2017-02-10

8.  Maternal and neonatal effects of substance abuse during pregnancy: our ten-year experience.

Authors:  Mirjana Vucinovic; Damir Roje; Zoran Vucinovic; Vesna Capkun; Marija Bucat; Ivo Banovic
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

9.  Opioid treatment for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-07-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.